Literature DB >> 22664972

High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing Escherichia coli in Japan.

Hisakazu Yano, Miho Ogawa, Shiro Endo, Risako Kakuta, Hajime Kanamori, Shinya Inomata, Noriomi Ishibashi, Tetsuji Aoyagi, Masumitsu Hatta, Yoshiaki Gu, Mitsuhiro Yamada, Koichi Tokuda, Hiroyuki Kunishima, Miho Kitagawa, Yoichi Hirakata, Mitsuo Kaku.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22664972      PMCID： PMC3421582          DOI： 10.1128/AAC.00617-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Authors:  H Yano; A Kuga; R Okamoto; H Kitasato; T Kobayashi; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Worldwide proliferation of carbapenem-resistant gram-negative bacteria.

Authors:  H Kurokawa; T Yagi; N Shibata; K Shibayama; Y Arakawa
Journal:  Lancet       Date:  1999-09-11       Impact factor: 79.321

3.  Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6.

Authors:  Norifumi Shigemoto; Ryuichi Kuwahara; Shizuo Kayama; Wataru Shimizu; Makoto Onodera; Michiya Yokozaki; Junzo Hisatsune; Fuminori Kato; Hiroki Ohge; Motoyuki Sugai
Journal:  Diagn Microbiol Infect Dis       Date:  2011-11-10       Impact factor: 2.803

4.  Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea.

Authors:  Yoonmi Seok; Il Kwon Bae; Seok Hoon Jeong; Soo Hyun Kim; Hyukmin Lee; Kyungwon Lee
Journal:  J Antimicrob Chemother       Date:  2011-09-19       Impact factor: 5.790

Review 5.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

6.  High prevalence of extended-spectrum β-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2.

Authors:  Hajime Kanamori; Hisakazu Yano; Yoichi Hirakata; Shiro Endo; Kazuaki Arai; Miho Ogawa; Masahiro Shimojima; Tetsuji Aoyagi; Masumitsu Hatta; Mitsuhiro Yamada; Katsushi Nishimaki; Miho Kitagawa; Hiroyuki Kunishima; Mitsuo Kaku
Journal:  J Antimicrob Chemother       Date:  2011-07-06       Impact factor: 5.790

7.  Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan.

Authors:  Hisaaki Nishio; Masaru Komatsu; Naohiro Shibata; Kouichi Shimakawa; Noriyuki Sueyoshi; Toshiro Ura; Kaori Satoh; Masahiro Toyokawa; Tatsuya Nakamura; Yasunao Wada; Tamaki Orita; Tomomi Kofuku; Katsutoshi Yamasaki; Masako Sakamoto; Shohiro Kinoshita; Masanori Aihara; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

8.  Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP.

Authors:  Y Hirakata; K Izumikawa; T Yamaguchi; H Takemura; H Tanaka; R Yoshida; J Matsuda; M Nakano; K Tomono; S Maesaki; M Kaku; Y Yamada; S Kamihira; S Kohno
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 9.  Meropenem: a review of its use in the treatment of serious bacterial infections.

Authors:  Claudine M Baldwin; Katherine A Lyseng-Williamson; Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem.

Authors:  Scott A Weisenberg; Daniel J Morgan; Rosanny Espinal-Witter; Davise H Larone
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-02       Impact factor: 2.803
  10 in total
  16 in total

1.  Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo.

Authors:  Kotaro Aoki; Sohei Harada; Koji Yahara; Yoshikazu Ishii; Daisuke Motooka; Shota Nakamura; Yukihiro Akeda; Tetsuya Iida; Kazunori Tomono; Satoshi Iwata; Kyoji Moriya; Kazuhiro Tateda
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Evaluation of the vitek 2 AST-N269 card for detection of meropenem resistance in imipenem-susceptible meropenem-resistant Enterobacteriaceae.

Authors:  Akira Koizumi; Kei Kasahara; Yuko Komatsu; Koji Ui; Fumiko Mizuno; Akifumi Nakayama; Keiichi Mikasa
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

3.  Suitability of Carbapenem Inactivation Method (CIM) for Detection of IMP Metallo-β-Lactamase-Producing Enterobacteriaceae.

Authors:  Kyoichi Saito; Ryuichi Nakano; Yuki Suzuki; Akiyo Nakano; Yoshihiko Ogawa; Shinsuke Yonekawa; Shiro Endo; Fumiko Mizuno; Kei Kasahara; Keiichi Mikasa; Mitsuo Kaku; Hisakazu Yano
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

4.  Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants.

Authors:  Zishuo Cheng; Christopher R Bethel; Pei W Thomas; Ben A Shurina; John-Paul Alao; Caitlyn A Thomas; Kundi Yang; Steven H Marshall; Huan Zhang; Aidan M Sturgill; Andrea N Kravats; Richard C Page; Walter Fast; Robert A Bonomo; Michael W Crowder
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

5.  Meropenem and chromacef intermediates observed in IMP-25 metallo-β-lactamase-catalyzed hydrolysis.

Authors:  Peter Oelschlaeger; Mahesh Aitha; Hao Yang; Joon S Kang; Antonia L Zhang; Eleanor M Liu; John D Buynak; Michael W Crowder
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

6.  The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary adaptation to meropenem exposure.

Authors:  Eleanor M Liu; Kevin M Pegg; Peter Oelschlaeger
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

7.  Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.

Authors:  Kayoko Hayakawa; Tohru Miyoshi-Akiyama; Teruo Kirikae; Maki Nagamatsu; Kayo Shimada; Kazuhisa Mezaki; Yuko Sugiki; Emi Kuroda; Shiho Kubota; Nozomi Takeshita; Satoshi Kutsuna; Masayoshi Tojo; Norio Ohmagari
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

8.  Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.

Authors:  Yuko Komatsu; Kei Kasahara; Takashi Inoue; Sang-Tae Lee; Tetsuro Muratani; Hisakazu Yano; Tadaaki Kirita; Keiichi Mikasa
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

9.  Rapid Identification of bla(IMP-1) and bla(IMP-6) by Multiplex Amplification Refractory Mutation System PCR.

Authors:  Akiyo Nakano; Ryuichi Nakano; Yuki Suzuki; Kyoichi Saito; Kei Kasahara; Shiro Endo; Hisakazu Yano
Journal:  Ann Lab Med       Date:  2018-07       Impact factor: 3.464

10.  Establishment of a dual-wavelength spectrophotometric method for analysing and detecting carbapenemase-producing Enterobacteriaceae.

Authors:  Dan Takeuchi; Yukihiro Akeda; Yo Sugawara; Noriko Sakamoto; Norihisa Yamamoto; Rathina Kumar Shanmugakani; Takuma Ishihara; Ayumi Shintani; Kazunori Tomono; Shigeyuki Hamada
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.